Ontario Teachers’ Pension Plan Board (a leading global institutional investor) and Nordic Capital (one of the most active and experienced investors in healthcare) globally agreed to jointly invest in Advanz Pharma, a global pharmaceutical company, to support Advanz’s development and further fuel its strong growth potential in the years to come.
Advanz is an international pharmaceutical company with a major focus on specialty, hospital, and rare disease pharmaceuticals.
It has commercial sales in over 90 countries globally, a direct presence in key European countries, the US, Canada, and Australia, and a Centre of Excellence for business support in Mumbai, India.
Advanz’s product portfolio and pipeline comprise innovative medicines, specialty generics and biosimilars, and originator brands. And Advanz addresses a broad range of therapeutic areas, including hepatology, gastroenterology, anti-infectives, critical care, endocrinology, CNS, and, more broadly, rare diseases. Following Nordic Capital’s initial investment in 2021, Advanz has scaled its European presence significantly and built a strong pipeline, including innovative rare disease medicines and biosimilars.
Nordic Capital had initially invested in Advanz Pharma in 2021 and will now invest via Nordic Capital XI, following the exit of its initial investment through Nordic Capital X.
Private Capital at Ontario Teachers’ has over C$60 billion of assets globally and uses its deep industry expertise and global network to make control or co-control investments in focus sectors. And with a dedicated global healthcare team, Ontario Teachers’ has deployed over C$5bn across 16 healthcare investments in its private capital portfolio, focusing on investments in life sciences, pharmaceutical services, medtech, and healthcare service providers.
Nordic Capital has assets under management of €30 billion. It invests in selected sectors and companies in Northern Europe and North America, offering partnerships, deep sector knowledge, capital, and experience to drive sustainable growth. It is one of the most active investors in healthcare globally, focusing on investing in companies within Medtech, Pharma, Care services, and Healthtech. To date, Nordic Capital has made 35 healthcare platform investments and has, in total, deployed €9.3 billion of equity capital in the sector.
The terms of the transaction were not disclosed, and the investment is subject to regulatory approvals.
KEY QUOTES:
“Advanz aligns well with our strategy of backing proven management teams in businesses with strong growth potential. With speciality pharmaceuticals a key area of focus for us in healthcare, we look forward to working together with Nordic Capital and the Advanz management team to support its existing and future pipeline, and drive innovation and growth across its global platform.”
- Jean-Charles Douin, Senior Managing Director and co-Head of EMEA Private Capital at Ontario Teachers’
“We are excited for Nordic Capital to continue its investment in Advanz together with Ontario Teachers’. This joint investment will support Advanz’s continued development in the years to come and allow the company to continue to scale its business model further and build on the market dynamics in its segment.”
- Rainer Lenhard, Partner, Nordic Capital Advisors
“During Nordic Capital’s ownership, Advanz has been transformed into a leading European specialty pharma platform by building a best-in-class infrastructure and successfully launching pipeline products during the last few years, enabling future growth in innovative medicines, and a strong track-record of executing on M&A opportunities.”
- Raj Shah, Partner and Head of Healthcare, Nordic Capital Advisors
“We are excited to continue our growth journey together with Nordic Capital and Ontario Teachers’. To have them jointly backing our growth ambitions validates our strategy, the capabilities of our team, and increases the positive impact we can deliver for patients.”
- Steffen Wagner, CEO, Advanz Pharma
